Shorla Pharma Announces Partnership with EVERSANA

CAMBRIDGE, MA — Shorla Pharma and EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced a partnership to support the launch and commercialization of Shorla’s oncology portfolio. The new partnership will initially focus on SH-111, an oncology drug designed to treat T-cell leukemia, currently pending U.S. FDA approval.

Read more at: https://www.prnewswire.com/news-releases/shorla-pharma-announces-partnership-with-eversana-to-support-the-launch-and-commercialization-of-t-cell-leukemia-treatment-301356204.html

LATEST NEWS